Exclude cheap drugs from price control: IPA

Sudarshan Jain, secretary general of IPA, in an interview to ET said "We are not against price controls; what we are saying is that the government should exclude low-priced scheduled products from price control or allow at least 10% annual hike as it is done for non-scheduled formulations," Jain said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Zwc0N1x
via IFTTT